Navigation Links
Augmentation Malar Implants

ProductsAugmentation Malar Implants
Company Spectrum Designs Medical
Item Augmentation Malar Implants
Features 
Description Anatomical Malar I Implants - Providing the surgeon with an anatomical shape, this implant follows the contour of the zygoma while adding moderate projection to the malar prominence.

Anatomical Malar II Implants - The anatomical shape of this implant provides the surgeon with another augumentation option that adds moderate projection to the malar prominence.

Extended Malar Implants - Designed to augument the malar to high projection of this implant specifically enhances the bone of the malar region.

Info Spectrum Designs Medical
Customer Service: 800-239-6399
Web site: http://www.spectrumdesignsmedical.com/index.htm

Related medicine products :

1. Universal Breast Augmentation Support
2. Sub Pectoral Breast Augmentation Wrap
3. NOW® Malaria Test (P. Falciparum)
4. Core Malaria Pv-Pf
5. Core Malaria Pf
6. OneStep Malaria (P.f /Vivax) RapiCard InstaTest
7. OptiMAL Malaria Test
8. Malaria P.f. Rapid Test Device
9. OptiMAL-IT Individual Rapid Malaria Test
10. ASSURE® Malaria P.f. Rapid Test
11. KAT-Quick Malaria test
Breaking Medicine Technology:Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 4Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 6Onyx Pharmaceuticals to Webcast Analyst Briefing on Development Program 2Hand Surgeons Take Ethics into Their Own Hands 2Hand Surgeons Take Ethics into Their Own Hands 3Hand Surgeons Take Ethics into Their Own Hands 4Mediterranean diet associated with reduced risk of depression 10311 1Mediterranean diet associated with reduced risk of depression 10311 2Common herbicides and fibrates block nutrient sensing receptor found in gut and pancreas 10307 1Common herbicides and fibrates block nutrient sensing receptor found in gut and pancreas 10307 2Miscarriage Treatment Wont Harm Future Fertility 3A Study 59205 1Miscarriage Treatment Wont Harm Future Fertility 3A Study 59205 2